SCHEMBL29892015

SCHEMBL29892015

N=C(N)NCCC[C@H](NC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 1/20 0.44
▸ KDM1A O60341 3/20 0.39
▸ MAPK8 P45983 1/20 0.39
▸ MAPK9 P45984 1/20 0.39
▸ MAPK10 P53779 1/20 0.39
▸ EPHA2 P29317 2/20 0.39
▸ MAOB P27338 1/20 0.38
▸ KDM5A P29375 1/20 0.38
▸ KDM1B Q8NB78 1/20 0.38
▸ NMUR2 Q9GZQ4 3/20 0.37
▸ NMUR1 Q9HB89 3/20 0.37
▸ CXCR4 P61073 1/20 0.37
▸ RAMP3 O60896 6/20 0.37
▸ CALCR P30988 6/20 0.37
▸ OPRM1 P35372 1/20 0.36
▸ OPRD1 P41143 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29406566 0.97 KEAP1 (0.43) KEAP1KDM1AMAPK8MAPK9MAPK10
SCHEMBL29892053 0.95 KEAP1 (0.41) KEAP1KDM1AMAPK8MAPK9MAPK10
SCHEMBL29489137 0.94 KEAP1 (0.39) KEAP1MAPK8MAPK9MAPK10NMUR2
SCHEMBL29777409 0.90 KEAP1 (0.41) KEAP1KDM1AMAPK8MAPK9MAPK10
SCHEMBL29517196 0.90 MEN1 (0.40) KDM1AMAPK8MAPK9MAPK10
SCHEMBL30444128 0.89 NMT1 (0.46) KDM1AMAOBKDM5AKDM1B
SCHEMBL30808875 0.89 KEAP1 (0.44) KEAP1MAPK8MAPK9MAPK10RAMP3
SCHEMBL30745230 0.89 MEN1 (0.41) KEAP1KDM1AMAPK8MAPK9MAPK10
SCHEMBL30564979 0.89 MEN1 (0.39) KEAP1KDM1AMAPK8MAPK9MAPK10
SCHEMBL30974174 0.88 KDM1A (0.38) KEAP1KDM1AMAPK8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240165006-A1 DERMATOLOGICAL COMPOSTIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2024-05-23 — — US claimed
EP-4313105-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF Bone Sci. Bio Ltd. (IL) 2024-02-07 — — EP claimed
US-20230130132-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF BONE SCI. BIO LTD. (IL) 2023-04-27 — — US claimed
EP-4125993-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF Bone Sci. Bio Ltd. (IL) 2023-02-08 — — EP claimed
WO-2022201146-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2022-09-29 — — WO claimed
US-20240165006-A1 DERMATOLOGICAL COMPOSTIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2024-05-23 — — US disclosed
EP-4313105-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF Bone Sci. Bio Ltd. (IL) 2024-02-07 — — EP disclosed
US-20230130132-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF BONE SCI. BIO LTD. (IL) 2023-04-27 — — US disclosed
EP-4125993-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF Bone Sci. Bio Ltd. (IL) 2023-02-08 — — EP disclosed
WO-2022201146-A1 DERMATOLOGICAL COMPOSITIONS AND USE THEREOF BONE SCI. BIO LTD. (IL) 2022-09-29 — — WO disclosed
Send feedback